Clearity

Clearity is a non-profit organization that has been operating since 2008 with the aim of revolutionizing the approach to ovarian cancer treatment. The company offers molecular profiling of tumors to enable healthcare practitioners and patients to make more informed decisions regarding treatment. Their team, consisting of scientists, physicians, and volunteers, advocates for a shift from the traditional trial-and-error methodology to a personalized therapy selection process based on individual tumor molecular profiles.

Clearity Foundation's range of services, including lab test coordination, tumor blueprint interpretation, and clinical trial identification, is provided free of charge. The organization prioritizes therapy options for recurrent and refractory ovarian cancer, educates patients and physicians about the value of molecular profiling in diagnosis and treatment, and expedites the clinical development of novel targeted agents for ovarian cancer by creating a database that correlates tumor molecular profiles with treatment outcomes.

Clearity operates in the Biotechnology and Health Care sectors, aiming to create a significant impact in the field of ovarian cancer treatment. As of the latest available data, details regarding their headquarters, last investment, and investors are not provided.